Common and uncommon histologic subtypes of renal cell carcinoma: Imaging spectrum with pathologic correlation

Radiographics

Volumn 26, Issue 6, 2006, Pages 1795-1806

  Prasad, Srinivasa R ^a   Humphrey, Peter A ^b   Catena, Jay R ^a   Narra, Vamsi R ^c   Srigley, John R ^d   Cortez, Arthur D ^a   Dalrymple, Neal C ^a   Chintapalli, Kedar N ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLASSIFICATION; CLINICAL PRACTICE; HUMAN; IMAGE ENHANCEMENT; KIDNEY CARCINOMA; KIDNEY TUMOR; METHODOLOGY; PATHOLOGY; PRACTICE GUIDELINE; RADIOGRAPHY; RARE DISEASE; REVIEW; STATISTICS;

CARCINOMA, RENAL CELL; HUMANS; IMAGE ENHANCEMENT; KIDNEY NEOPLASMS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; RARE DISEASES; STATISTICS;

EID: 34250332941     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.266065010     Document Type: Review

References (40)

1. Eble JN, Sauter G, Epstein JI, Sesterhenn IA, eds. Pathology and genetics of tumours of the urinary system and male genital organs. Lyon, France: IARC Press, 2004.
2. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004;54:8-29.
3. Lane BR, Kattan MW. Predicting outcomes in renal cell carcinoma. Curr Opin Urol 2005;15:289-297.
4. Mathew A, Devesa SS, Fraumeni JF Jr, Chow WH. Global increases in kidney cancer incidence, 1973-1992. Eur J Cancer Prev 2002;11:171-178.
5. Leslie JA, Prihoda T, Thompson IM. Serendipitous renal cell carcinoma in the post-CT era: continued evidence in improved outcomes. Urol Oncol 2003;21:39-44.
6. Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 2003;27:612-624.
7. Sukosd F, Kuroda N, Beothe T, Kaur AP, Kovacs G. Deletion of chromosome 3p14.2-p25 involving the VHL and FHIT genes in conventional renal cell carcinoma. Cancer Res 2003;63:455-457.
8. Jones TD, Eble JN, Cheng L. Application of molecular diagnostic techniques to renal epithelial neoplasms. Clin Lab Med 2005;25:279-303.
9. Linehan WM, Vasselli J, Srinivasan R, et al. Genetic basis of cancer of the kidney: disease-specific approaches to therapy. Clin Cancer Res 2004;10(18 pt 2):6282S-6289S.
10. Lubensky IA, Schmidt L, Zhuang Z, et al. Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype. Am J Pathol 1999;155:517-526.
11. Polascik TJ, Bostwick DG, Cairns P. Molecular genetics and histopathologic features of adult distal nephron tumors. Urology 2002;60:941-946.
12. Cheng WS, Farrow GM, Zincke H. The incidence of multicentricity in renal cell carcinoma. J Urol 1991;146:1221-1223.
13. Shinmoto H, Yuasa Y, Tanimoto A, et al. Small renal cell carcinoma: MRI with pathologic correlation. J Magn Reson Imaging 1998;8:690-694.
14. Soyer P, Dufresne A, Klein I, Barbagelatta M, Herve JM, Scherrer A. Renal cell carcinoma of clear type: correlation of CT features with tumor size, architectural patterns, and pathologic staging. Eur Radiol 1997;7:224-229.
15. Yoshimitsu K, Irie H, Tajima T, et al. MR imaging of renal cell carcinoma: its role in determining cell type. Radiat Med 2004;22:371-376.
16. Kim JK, Kim TK, Ahn HJ, Kim CS, Kim KR, Cho KS. Differentiation of subtypes of renal cell carcinoma on helical CT scans. AJR Am J Roentgenol 2002;178:1499-1506.
17. Jinzaki M, Tanimoto A, Mukai M, et al. Double-phase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumor angiogenesis. J Comput Assist Tomogr 2000;24:835-842.
18. Cohen HT, McGovern FJ. Renal-cell carcinoma. N Engl J Med 2005;353:2477-2490.
19. Outwater EK, Bhatia M, Siegelman ES, Burke MA, Mitchell DG. Lipid in renal clear cell carcinoma: detection on opposed-phase gradient-echo MR images. Radiology 1997;205:103-107.
20. Moch H, Gasser T, Amin MB, Torhorst J, Sauter G, Mihatsch MJ. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors. Cancer 2000;89:604-614.
21. Ishikawa I, Kovacs G. High incidence of papillary renal cell tumours in patients on chronic haemodialysis. Histopathology 1993;22:135-139.
22. Delahunt B, Eble JN, McCredie MR, Bethwaite PB, Stewart JH, Bilous AM. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases. Hum Pathol 2001;32:590-595.
23. Herts BR, Coll DM, Novick AC, et al. Enhancement characteristics of papillary renal neoplasms revealed on triphasic helical CT of the kidneys. AJR Am J Roentgenol 2002;178:367-372.
24. Choyke PL, Glenn GM, Walther MM, Zbar B, Linehan WM. Hereditary renal cancers. Radiology 2003;226:33-46.
25. Lesavre A, Correas JM, Merran S, Grenier N, Vieillefond A, Helenon O. CT of papillary renal cell carcinomas with cholesterol necrosis mimicking angiomyolipomas. AJR Am J Roentgenol 2003;181:143-145.
26. Storkel S, Steart PV, Drenckhahn D, Thoenes W. The human chromophobe cell renal carcinoma: its probable relation to intercalated cells of the collecting duct. Virchows Arch B Cell Pathol Incl Mol Pathol 1989;56:237-245.
27. Mugiya S, Nagata M, Ozono S, et al. Ultrasonographic features of chromophobe cell renal carcinoma [in Japanese]. Hinyokika Kiyo 2004;50:865-868.
28. Kondo T, Nakazawa H, Sakai F, et al. Spoke-wheel-like enhancement as an important imaging finding of chromophobe cell renal carcinoma: a retrospective analysis on computed tomography and magnetic resonance imaging studies. Int J Urol 2004;11:817-824.
29. Renshaw AA, Henske EP, Loughlin KR, Shapiro C, Weinberg DS. Aggressive variants of chromophobe renal cell carcinoma. Cancer 1996;78:1756-1761.
30. Srigley JR, Eble JN. Collecting duct carcinoma of kidney. Semin Diagn Pathol 1998;15:54-67.
31. Prasad SR, Humphrey PA, Menias CO, et al. Neoplasms of the renal medulla: radiologic-pathologic correlation. RadioGraphics 2005;25:369-380.
32. Pickhardt PJ, Siegel CL, McLarney JK. Collecting duct carcinoma of the kidney: are imaging findings suggestive of the diagnosis? AJR Am J Roentgenol 2001;176:627-633.
33. Davis CJ Jr, Mostofi FK, Sesterhenn IA. Renal medullary carcinoma: the seventh sickle cell nephropathy. Am J Surg Pathol 1995;19:1-11.
34. Davidson AJ, Choyke PL, Hartman DS, Davis CJ Jr. Renal medullary carcinoma associated with sickle cell trait: radiologic findings. Radiology 1995;195:83-85.
35. Weber A, Srigley J, Moch H. Mucinous spindle cell carcinoma of the kidney: a molecular analysis [in German]. Pathologe 2003;24:453-459.
36. Bruder E, Passera O, Harms D, et al. Morphologic and molecular characterization of renal cell carcinoma in children and young adults. Am J Surg Pathol 2004;28:1117-1132.
37. Medeiros LJ, Palmedo G, Krigman HR, Kovacs G, Beckwith JB. Oncocytoid renal cell carcinoma after neuroblastoma: a report of four cases of a distinct clinicopathologic entity. Am J Surg Pathol 1999;23:772-780.
38. Kovacs G, Emanuel A, Neumann HP, Kung HF. Cytogenetics of renal cell carcinomas associated with von Hippel-Lindau disease. Genes Chromosomes Cancer 1991;3:256-262.
39. Pavlovich CP, Walther MM, Eyler RA, et al. Renal tumors in the Birt-Hogg-Dube syndrome. Am J Surg Pathol 2002;26:1542-1552.
40. Upton MP, Parker RA, Youmans A, McDermott DF, Atkins MB. Histologic predictors of renal cell carcinoma response to interleukin-2-based therapy. J Immunother 2005;28:488-495.